Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

FoxA is crucial for planarian pharynx regeneration.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

The FTO gene hinders stem cells in hair follicles from becoming pigment cells.

Certain immune cells in the skin can stop hair from growing.

The LTF gene may help predict and manage nonspecific orbital inflammation.

KLF4 is important for keeping hair follicle stem cells inactive.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Human hair follicle stem cells can be turned into red blood cells.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Targeting specific T cells may help treat alopecia areata.

HT-scCAT-seq helps understand gene regulation in embryonic skin development.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Mice without the Sept4/ARTS gene heal wounds better due to more stem cells that don't die easily.

Lhx2 helps retinal cells respond to signals for eye development.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Sonic hedgehog signaling is needed for the development of touch-receptor cells in the skin, and the loss of Polycomb repressive complex 2 can lead to more of these cells.

LGD1069 effectively prevents breast tumors in mice without toxicity.

ILC1-like cells can cause alopecia areata by themselves.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

FOXN1 duplication can cause excessive hair growth.